Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathella Pavan Kumar

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Impact of diabetes mellitus on immunity to latent tuberculosis infectionNathella Pavan Kumar, Subash Babu
Plos One|January 5, 2016
Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary TuberculosisNathella Pavan Kumar, Vaithilingam V Banurekha, Dina Nair, et al.
Plos One|April 28, 2017
Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatmentNathella Pavan Kumar, Vaithilingam V Banurekha, Dina Nair, et al.
Plos One|May 31, 2017
Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infectionNathella Pavan Kumar, Kadar Moideen, Chandrakumar Dolla, et al.
Open Forum Infectious Diseases|July 9, 2019
Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary TuberculosisNathella Pavan Kumar, Kadar Moideen, Vaithilingam V Banurekha, et al.
The American Journal of Tropical Medicine and Hygiene|September 6, 2018
Altered Systemic Adipokine Levels in Pulmonary Tuberculosis and Changes following TreatmentKadar Moideen, Nathella Pavan Kumar, Dina Nair, et al.
Journal of Immunology Research|March 4, 2022
High Dimensionality Reduction and Immune Phenotyping of Natural Killer and Invariant Natural Killer Cells in Latent Tuberculosis-Diabetes ComorbidityGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Tuberculosis (Edinburgh, Scotland)|August 6, 2021
Ex-vivo immunophenotyping and high dimensionality UMAP analysis of leucocyte subsets in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Rathinam Sridhar, et al.
Cytokine|April 24, 2018
Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokinesNathella Pavan Kumar, Kadar Moideen, Vaithilingam V Banurekha, et al.
Frontiers in Cellular and Infection Microbiology|November 12, 2021
Decreased Frequencies of Gamma/Delta T Cells Expressing Th1/Th17 Cytokine, Cytotoxic, and Immune Markers in Latent Tuberculosis-Diabetes/Pre-Diabetes ComorbidityGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Impact of diabetes mellitus on immunity to latent tuberculosis infectionNathella Pavan Kumar, Subash Babu
Plos One|January 5, 2016
Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary TuberculosisNathella Pavan Kumar, Vaithilingam V Banurekha, Dina Nair, et al.
Plos One|April 28, 2017
Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatmentNathella Pavan Kumar, Vaithilingam V Banurekha, Dina Nair, et al.
Plos One|May 31, 2017
Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infectionNathella Pavan Kumar, Kadar Moideen, Chandrakumar Dolla, et al.
Open Forum Infectious Diseases|July 9, 2019
Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary TuberculosisNathella Pavan Kumar, Kadar Moideen, Vaithilingam V Banurekha, et al.
The American Journal of Tropical Medicine and Hygiene|September 6, 2018
Altered Systemic Adipokine Levels in Pulmonary Tuberculosis and Changes following TreatmentKadar Moideen, Nathella Pavan Kumar, Dina Nair, et al.
Journal of Immunology Research|March 4, 2022
High Dimensionality Reduction and Immune Phenotyping of Natural Killer and Invariant Natural Killer Cells in Latent Tuberculosis-Diabetes ComorbidityGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Tuberculosis (Edinburgh, Scotland)|August 6, 2021
Ex-vivo immunophenotyping and high dimensionality UMAP analysis of leucocyte subsets in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Rathinam Sridhar, et al.
Cytokine|April 24, 2018
Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokinesNathella Pavan Kumar, Kadar Moideen, Vaithilingam V Banurekha, et al.
Frontiers in Cellular and Infection Microbiology|November 12, 2021
Decreased Frequencies of Gamma/Delta T Cells Expressing Th1/Th17 Cytokine, Cytotoxic, and Immune Markers in Latent Tuberculosis-Diabetes/Pre-Diabetes ComorbidityGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Pageof 10